4-Methylbuphedrone
![]() | |
Systematic (IUPAC) name | |
---|---|
2-(methylamino)-1-(4-methylphenyl)-1-butanone | |
Clinical data | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | 1336911-98-8 |
PubChem | CID 71750237 |
ChemSpider | 26702147 |
Chemical data | |
Formula | C12H17NO |
Molar mass | 191.27 g/mol |
| |
|
4-Methylbuphedrone (also known as 4-MeMABP, BZ-6378 and 4-Methyl-α-methylamino-butyrophenone), is a stimulant drug of the cathinone class that has been sold online as a designer drug.[1][2][3]
It was first reported to the EMCDDA in November 2011.[4]
Legal status
4-Methylbuphedrone is listed in Anlage I and therefore illegal in Germany.
As of October 2015 4-MeMABP is a controlled substance in China.[5]
See also
References
- ↑ "4-Methylbuphedrone". Cayman Chemical. Retrieved 16 July 2015.
- ↑ Nahoko Uchiyama, Satoru Matsuda, Maiko Kawamura, Ruri Kikura-Hanajiri, Yukihiro Goda (January 2014). "Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products". Forensic Toxicology 32 (1): 9–18. doi:10.1007/s11419-013-0194-5.
- ↑ Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura-Hanajiri, Yukihiro Goda (April 2013). "URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products.". Forensic Science International 227 (1–3): 21–32. doi:10.1016/j.forsciint.2012.08.047. PMID 23063179.
- ↑ Christophe Soussan, Anette Kjellgren (September 2014). "Harm reduction and knowledge exchange—a qualitative analysis of drug-related Internet discussion forums". Harm Reduction Journal 11 (25). doi:10.1186/1477-7517-11-25. PMID 25200686.
- ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.